NCT00006207View on ClinicalTrials.gov

Safety and Tolerability of the Vaginal Gel PRO 2000/5

PHASE1CompletedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

Not specified

Conditions

HIV Infections

Interventions

DRUG

PRO 2000

Trial Locations (1)

27709

Julia Welch, Research Triangle Park

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Procept

INDUSTRY

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH